Immunic Inc (NASDAQ:IMUX)
| 9.75 Delayed Data As of Sep 27 |  +0.53 / +5.75%Today’s Change | 7.69 Today|||52-Week Range 28.21 | -36.23% Year-to-Date |
Latest IMUX News | Press Releases
No recent news for Immunic Inc.
Today’s Trading
| Previous close | 9.22 |
| Today’s open | 9.17 |
| Day’s range | 9.17 - 9.79 |
| Volume | 2,075 |
| Average volume (3 months) | 197,827 |
| Market cap | $245.7M |
Data as of 4:14pm ET, 09/27/2021
Growth & Valuation
| Earnings growth (last year) | +37.88% |
| Earnings growth (this year) | -44.17% |
| Earnings growth (next 5 years) | +15.51% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.23 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OSMTOsmotica Pharmaceuti... | +0.10 | +3.47% |
| ---- | ||
| FENCFennec Pharmaceutica... | -0.04 | -0.43% |
| GMDAGamida Cell Ltd | +0.05 | +1.24% |
Data as of 4:14pm ET, 09/27/2021
Financials
| Next reporting date | November 11, 2021 |
| EPS forecast (this quarter) | -$0.81 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$44.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
